(A, B) Immunofluorescence for different marker genes (maximal intensity projection along z). Yellow arrowhead in (B) points to higher NANOG expression in PGCLCs than pluripotent cells in the colony …
(A–F) Additional stainings of micropatterned colonies and spatial distribution of positive cells. (G) Breakdown of cell populations corresponding to Figure 1G and (E, F). (H, I) Normalized radial …
(A, B) Comparison of immunofluorescence (IF) for ISL1, TBXT, SOX2 with their expression on the PHATE visualization of the scRNA-seq data. (C) Primordial germ cells (PGCs) budding off as a lineage …
Each row shows immunofluorescence (IF) and quantification for PGC markers in different cell lines. (A–C) ESI017, also shown in Figure 1B, shown here for comparison. (E–F) PGP1, male induced …
(A, B) Immunofluorescence over time showing a stable PGC population and later emergence of endoderm. (C) Quantification of marker expression at different times showing the emergence of endoderm …
(A) DAPI staining for colonies shown in Figure 2A and B. (B) Radial profile of marker expression at different times. (C) Overlay of colonies from Figure 2A and B, including DAPI, showing location of …
(A, B) Separate channels for Figure 2G. (C) Scatterplots of corresponding quantification.
Each row shows staining and quantification of PGC markers after perturbation of different pathways. Error bands in spatial distributions are omitted for clarity but are similar in magnitude to Figure…
(A) Overlay and separate channels for Figure 3A. (B) scatterplot of PRDM1 vs. TBXT for BMP4-treated colonies with or without BMP-receptor inhibition after 24 hr, colored for the condition. (C) …
(A, B) Wnt inhibition (WNTi, IWP2, 5 µM) with different doses of Activin, for example, A3 = 3 ng/ml Activin. (C–E) Activin rescue of WNTi at 0 hr vs. 12 hr with LEF1 staining. (F–H) Like (C–E) but …
(A, B) Individual channels for Figure 4A and C. (C) IWR-1 does not block PGC specification at 10 µM. (D) Individual channels for Figure 4F (IWR-1 inhibition at 50 µM and rescue of PGCs by Activin). …
(A–C) Images of individual channels for Figure 4K, M, and R. (A) corresponds to Figure 4K, (B) to Figure 4M, (C) to Figure 4R. (D, E) Effect of exogenous Activin timing on cell fate in NodalKO …
(A–D) Different diameter colonies stained for TFAP2C, SOX17, EOMES at 42 hr and quantification, (B) SOX17 vs. TFAP2C scatterplot colored for colony size. (C) Same plot colored for EOMES expression. …
(A, B) Staining for PGC markers and quantification after treatment with Activin for 24 hr followed by inhibition of TGFb signaling by SB431542 (compare Figure 4R). (C) Scatterplots corresponding to …
(A) Input signaling profile in space and time. (B) Diagram of the model. (C) Definition of the model. (D) Phase diagram showing predicted expression of cell fate markers at steady state for …
Each row shows a model and its predicted patterns for the perturbations we wanted to explain. (A) Stable primordial germ cell-like cells (PGCLCs) through autoregulation of SOX17 in combination with …
Reagent | Nickname | Vendor, catalog # | Dose | Function |
---|---|---|---|---|
rhBMP4 | BMP4 | R&D Systems, #314BP/CF | See figures | Activate BMP pathway |
rhActivin | A | R&D Systems, #AFL338 | See figures | Activate TGFb pathway |
CHIR-99021 | C | Tocris, #4423 | See figures | Canonical Wnt agonist |
IWP 2 | WNTi | Tocris, #3533 | 5 µM unless stated otherwise | Block Wnt secretion |
IWR-1 | cWNTi | Thermo Fisher, 50-101-4191 | 50 µM unless stated otherwise | Block canonical Wnt signaling |
LDN-193189 | BMPRi | MedChemExpress, # HY-12071 | 250 nM | Block BMP signaling |
SB-431542 | TGFBRi | Apexbio, #A8249 | 10 µM | Block TGFb signaling |
PD-0325901 | MEKi | ESIBIO, #ST10009 | 5 µM | Block MEK signaling |
PD-173074 | FGFRi | MedChemExpress, #HY-10321 | 1 µM | Block FGF signaling |
Protein | Species | Dilution | Catalog # | Vendor |
---|---|---|---|---|
ISL1 | Mouse | 1:200 | 39.4D5 | DSHB |
SOX2 | Rabbit | 1:200 | 3579S | Cell Signaling Technology |
TBXT (BRA) | Goat | 1:300 | AF2085 | R&D Systems |
PRDM1 (BLIMP1) | Rat | 1:50 | SC-47732 | Santa Cruz Biotechnology |
SOX17 | Goat | 1:200 | AF1924 | R&D Systems |
TFAP2C | Mouse | 1:150 | SC-12762 | Santa Cruz Biotechnology |
NANOG | Goat | 1:100 | AF1997 | R&D Systems |
EOMES (TBR2) | Rabbit | 1:500 | AB23345 | Abcam |
POU5F1 | Mouse | 1:400 | 611,202 | BD Biosciences |
LEF1 | Rabbit | 1:200 | C12A5 | Cell Signaling Technology |
Protein | Species | Dilution | Catalog # | Vendor |
---|---|---|---|---|
Alexa Fluor 647 anti-goat | Donkey IgG | 1:500 | A21447 | Thermo Fisher Scientific |
Alexa Fluor 555 anti-goat | Donkey IgG | 1:500 | A21432 | Thermo Fisher Scientific |
Alexa Fluor 488 anti-mouse | Donkey IgG | 1:500 | A21202 | Thermo Fisher Scientific |
Alexa Fluor 647 anti-rat | Whole IgG | 1:500 | 112-605-167 | Jackson ImmunoResearch |
Alexa Fluor 647 anti-rabbit | Donkey IgG | 1:500 | A31573 | Thermo Fisher Scientific |
Alexa Fluor 555 anti-rabbit | Donkey IgG | 1:500 | A31572 | Thermo Fisher Scientific |
GAPDH | ACAACTTTGGTATCGTGGAAGG | GCCATCACGCCACAGTTTC |
SOX17 | GTGGACCGCACGGAATTTG | GGAGATTCACACCGGAGTCA |
NANOS3 | CTTTGACCTGTGGACAGATTACC | GCCTGGTTTCAGGACCCTC |
DPPA3 | TTAATCCAACCTACATCCCAGGG | AGGGGAAACAGATTCGCTACTA |
DDX4 | TTGTTGCTGTTGGACAAGTGGGTG | GCAACAAGAACTGGGCACTTTCCA |
EOMES | CGCCACCAAACTGAGATGAT | CACATTGTAGTGGGCAGTGG |
PRDM1 | CTACCCTTATCCCGGAGAGC | GGACATTCTTTGGGCAGAGT |
Parameter | Value | Meaning |
---|---|---|
n | 2 | Hill function coefficient |
0.1733 | Protein dilution + degradation rate | |
0.173 | Production rate for and | |
1 | Autoactivation steady state for and | |
(0.313, 0.338, 0.371, 1.2) | Signaling thresholds | |
Inhibition thresholds | ||
(0.269, 0.135) | Maximum signaling-driven protein level | |
Autoactivation thresholds | ||
0.5 | activation threshold for on and | |
100 | dimerization constant for |
List of gastrulation genes used for visualization and clustering.
Most differentially expressed genes in clusters found in scRNA-seq data.
Most differentially expressed genes from Supplementary file 1 in clusters found in scRNA-seq data.